Discovery and Research

Discovery from public oncological data using QIAGEN Omicsoft OncoLand and QIAGEN Ingenuity Pathway Analysis - June 17 2021

June 24, 2021
In this 90-minute training, we will discuss how to discover and validate biomarkers as well as drug targets and key genes using public oncological data from GEO, TCGA, CCLE and other sources. To do this, we will use QIAGEN Omicsoft OncoLand, QIAGEN Ingenuity Pathway Analysis (IPA) and the OmicSoft Land Explorer web interface.

Specifically, for conditions of interest (diseases, cell lines, treatments etc.), we will discuss how to:
• Identify public studies of interest
• Derive a biomarker/gene signature
• Study expression of a gene or drug target
• Correlate expression of multiple genes and biomarkers
• Visualize a gene signature in the context of a heatmap
• Compare public data with other public data or a user’s own data

Speaker: Sumana Chintalapudi, Ph.D., Field Application Scientist, QIAGEN Digital Insights

Related videos

Discovery and Research

Multi-omic changes in the postnatal mouse heart identified by QIAGEN Ingenuity Pathway Analysis...

413 views May 18, 2020

Multi-omics experiments allow researchers to make important discoveries in...

Discovery and Research

Using QIAGEN Digital Insights to determine how LY6E impairs coronavirus fusion and confers immune...

507 views May 08, 2020

Zoonotic coronaviruses (CoVs) are significant threats to global health, as...

Discovery and Research

Transcriptomics, Proteomics and Metabolic Changes in Post-Natal Mouse Heart analyzed with...

771 views November 07, 2019

In this talk, Jean-Noël Billaud, Ph.D. Senior Principal Scientist, QIAGEN...

Discovery and Research

Exploring Single-Cell Transcriptomes Using Bioinformatics Solutions from QIAGEN - Part 1

1,465 views May 13, 2019

Cells – the basic building blocks of organisms – are each quite unique....